Lyrus Life Sciences Private Limited - Charges

Every charge - open or closed - that lenders have registered against Lyrus Life Sciences Private Limited, with the most recent activity at t…

2015-06-16 Bangalore, Karnataka Active Unlisted Active Compliant
Share
View plans Plan
LL Lyrus Life Sciences Private Limited
View plans Plan
Open charges
1
30.00 cr
Closed charges
2
56.63 cr
Total
3
86.63 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Canara Bank 1 38.13 cr
2 Others 1 30.00 cr
3 State Bank Of India 1 18.50 cr
All charges (3) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
101044298 Others 07 Feb 2025 - - 30.00 cr Open
100874309 State Bank Of India 28 Feb 2024 - 10 Feb 2025 18.50 cr Closed
100203676 Canara Bank 04 Sep 2018 30 May 2023 26 Feb 2024 38.13 cr Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Lyrus Life Sciences Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Lyrus Life Sciences Private Limited (CIN: U24230KA2015PTC080902). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Lyrus Life Sciences Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.